'Smart bomb' drug approved for late-stage beast cancer patients
Kadcyla can work up to 20 percent of all breast cancer sufferers
The "smart bomb" drug called Kadacyl could possibly help one fifth of sufferers in late-stage of the disease now that it has been approved by the Food and Drug Administration. The producers of Kadacyl, Genentech say the drug has added almost six months onto the lives of late-stage cancer sufferers in a clinical trial.
Kadacyl is a combination of the well-known drug Herceptin and a chemotherapy drug called DM1, which is too powerful to go straight into the bloodstream.
The drug has been proven effective on HER2-positive breast cancer, a protein which advances cancer growth, adding several months onto the life of many women who were facing death.
Human trials on 991 women with advanced stage HER2-positive breast cancer were found to have extended their lives by an average of 5.8 months compared to standard chemotherapy.
It's estimated that 20 percent of breast cancer sufferers suffer from HER2 protein breast cancer.
Breast cancer is the second most deadly type of cancer among American women. It's estimated that 232,340 women will be diagnosed with breast cancer and 39,620 will die as a result of the illness.
Genentech says the drug will be available in two weeks. NBC reports it is expensive at a cost of $94,000 for a 10 month course.
Genentech said it would help patients who couldn't afford to make the payments. "People who do not have health insurance, or who have reached the lifetime limit set by their insurance company, might qualify to receive Kadcyla free of charge," it said in the statement.
"Kadcyla is an antibody-drug conjugate representing a completely new way to treat HER2-positive metastatic breast cancer, and it helped people live nearly six months longer," Chief medical officer and Head of Global Product Development, Hal Barron, says.
"We currently have more than 25 antibody-drug conjugates in our pipeline and hope this promising approach will help us deliver more medicines to fight other cancers in the future."
© 2014 - Distributed by THE NEWS CONSORTIUM
Pope Francis Prayer Intentions for March 2014
Respect for Women: That all cultures may respect the rights and dignity of women.
Vocations: That many young people may accept the Lordís invitation to consecrate their lives to proclaiming the Gospel.
Rate This Article
Leave a Comment
More Health News
- New blood test diagnoses Alzheimer's three years before onset of disease
- Malaria spreads to higher altitudes due to global warming
- Malaria cases spread to higher elevations
- Alzheimer's to join cancer, heart disease as one of America's top fatal conditions
- Birthing centers not provided for under health care reform
- Lots of proteins can BE BAD FOR YOU! 'As bad for health as smoking,' new study finds
- OUTBREAK: 53 people in 10 states stricken with measles
- Popular overdose drug rises in cost, to keep up with demand
- ANCIENT SCOURGE: leprosy, still very much alive in the world today, goes back 10 million years
- Fr. Paul Schenck: Finding Living Faith on Catechetical Sunday
- The Movie Yellow: Incest as 'Normal' and Cassavates's Slides Into the World of Woes
- The Chicago School Teachers Strike Reveals the Need For School Choice
- The Sexual Barbarians and the Dissolution of Culture
- The Happy Priest Challenges Us to Ask: Who is Jesus to Me?
- Michael Coren on Canadian Public Schools: Teachers, leave those kids alone
- We Cannot Ignore Our Consciences: Cardinal Dolan On Religious Liberty
- In the Face of Danger, Successor of Peter Travels to Lebanon as a Messenger of Peace
- Reflections on the Dignity and Vocation of Women: Who or What?